Start an analysis for KROS
Keros Therapeutics, Inc.
Stock · NASDAQ- AuthorizationKeros Therapeutics, Inc. authorizes $5m share repurchase program 8-K filed 16-Nov-26
- QuarterKeros Therapeutics, Inc. repurchased 146,342 shares ($2m) in the quarter to Sep 30, 2026 10-Q filed 05-Nov-26
- AuthorizationKeros Therapeutics, Inc. authorizes $5m share repurchase program 10-Q filed 05-Nov-26